Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

FDA authorises first therapy to tackle cortisol overproduction in Cushing’s disease

March 9, 2020 Sales and Marketing Cushing's disease, FDA, pharma

The FDA has moved to approve its first therapy to directly treat the overproduction of the hormone cortisol which is …
News

Coronavirus forcing Eli Lilly employees to work from home

March 9, 2020 Sales and Marketing Chinese Coroanvirus, Eli Lilly, Eli Lilly Coronavirus, Wuhan Coronavirus, coronavirus

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …
News
20181130-niaid-hiv-test

Uganda finalising clinical trials on new injectable HIV drug

March 9, 2020 Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …
News
nice_new_london_office_internal_3_web

NICE shoots down Dupixent for severe asthma

March 9, 2020 Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …
News
4420456374_64a3d7e6aa_75

Top Ten most popular articles on Pharmafile.com this week

March 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus, wuhan coronavirus.

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …
News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020 Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
News

China approves Roche’s Actemra to fight severe complications stemming from coronavirus

March 5, 2020 Sales and Marketing Actemra, China, Roche, coronavirus, pharma

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …
News
gilead_hq_at_stockley_park_london_2

Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal

March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma

Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …
News

Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma

March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma

Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …
News
michael-jewell

Funding overview for the pharmaceutical industry and outlook for 2020

March 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …
Feature
gwpharma

GW Pharma takes back control of UK Sativex sales from Bayer

March 2, 2020 Sales and Marketing Bayer, GW Pharma, Sativex, UK

British firm GW Pharmaceuticals has revealed that it plans to reclaim the commercialisation rights to market its cannabis-based multiple sclerosis …
News
26629351446_42eeafa009_b_1

UK Health Secretary says no tactics will be “off the table” in dealing with coronavirus

March 2, 2020 Sales and Marketing Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

British Health Secretary Matt Hancock has said nothing will be “off the table” in tackling the coronavirus as cases in …
News
martin_shkreli_2016

FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim

March 2, 2020 Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma

The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …
News
1024px-u

Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces

March 2, 2020 Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance

The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …
News
170124-f-ds634-005

Experimental drug could treat dyskinesia in people with Parkinson’s

March 2, 2020 Sales and Marketing Parkinson's, Parkinson's disease, dyskinesia, spasms

Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025